Zadzwoń do nas: +48 697 666 117

A Wealth of Pharmaceutical Experience

Curaleaf International (the "Company"), part of Curaleaf Holdings (TSX:CURA) and Europe's largest vertically integrated cannabis company, is pleased to announce its acquisition of Can4Med, a prominent pharmaceutical wholesaler specializing in cannabinoid medications in Poland.

CAN4MED S.A deals with the sale of medicinal products, pharmaceutical raw materials for pharmacy prescription, wholesale of narcotics from group I-N including the herb hemp other than fibrous and extracts, pharmaceutical tinctures, as well as other extracts from hemp other than fibrous.

 
 Supplying a fast growing market
 

Since the legalization of medical cannabis in Poland in 2017 the number of prescriptions for cannabinoid-based medications has been steadily rising, with actual eligibility calculated at several hundred thousands of patients. 

 

In this market Can4Med offers:

 

  • WIDE RANGE OF PRODUCTS 
  • FACILITATED ACCESS FOR PHARMACIES AND LICENSED PRODUCERS 
  • EXTENSIVE EXPERIENCE IN THE FIELD

 

Working with the market leaders

With our close cooperation with the principal licensed producers, we are able to provide
pharmacies with fast and facilitated access to medical cannabis. While already offering a wide
selection of strains and varieties, we are continuously working on expanding the range of medical
cannabis products available in Poland.